GENMARK DIAGNOSTICS, INC.
CIK 0001487371
Revenue (TTM)
$140.79M
+94.8% YoY
FY Feb 2021
Net Income (TTM)
−$26.6M
−15.4% YoY
FY Feb 2021
EPS Diluted (TTM)
—
FY Feb 2021
Gross Margin
39.5%
FY Feb 2021
Operating Margin
-13.7%
FY Feb 2021
Net Margin
-18.9%
FY Feb 2021
Free Cash Flow (TTM)
−$41.04M
FY Feb 2021
Cash
$40.57M
FY Feb 2021
Total Debt
$74.73M
FY Feb 2021
Shares Outstanding
73.09M sh
FY Feb 2021